Patents by Inventor Francis Xavier Tavares

Francis Xavier Tavares has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors
    Patent number: 7282512
    Abstract: Cycloalkyl ketoamide derivatives, which are useful as cathepsin K inhibitors are described herein. The described invention also includes methods of making such cycloalkyl ketoamide derivatives as well as methods of using the same in the treatment of disorders, including osteoporosis, associated with enhanced bone turnover which can ultimately lead to fracture.
    Type: Grant
    Filed: January 15, 2003
    Date of Patent: October 16, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: John George Catalano, David Norman Deaton, Aaron Bayne Miller, Francis Xavier Tavares
  • Pyrazolopyridazine derivatives
    Patent number: 7279473
    Abstract: Fused pyradazine derivatives which are usefule as CDK inhibitors are described herein. The described invention alos includes methods of making such fused pyradazine derivatives as wells as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Grant
    Filed: December 11, 2002
    Date of Patent: October 9, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Jennifer G. Badiang, Scott Howard Dickerson, Philip Anthony Harris, David Kendall Jung, Michael Robert Peel, Michael John Reno, Tara Renae Rheault, Kirk Lawrence Stevens, Francis Xavier Tavares, James Marvin Veal